“Guy Levy”

As a Name:  Registrant, Group Member and/or Signatory

        

Latest Filing:  4/16/24  as  ↓Group Member

As:  Registrant

        

As:  Group Member  (Co-Filer Non-Registrant:  Partner, Affiliate, etc.)

“Guy Levy” has been a Group Member with  3  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
4/16/24		CT	Soleus Private Equity Fund I, L.P.	11	SC 13D/A	CA	BioAtla, Inc.
2/9/24			Soleus Capital Master Fund, L.P.	50	SC 13G/A	MN	Celcuity Inc.
2/6/24		CT	Soleus Private Equity Fund III, L.P.	6	SC 13G/A	CA	Harpoon Therapeutics, Inc.

“Guy Levy” has/had a Group Member interest in  25  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
4/16/24		CA	BioAtla, Inc.	5	SC 13D/A	CT	Soleus Private Equity Fund I, L.P.
2/9/24		MN	Celcuity Inc.	3	SC 13G/A		Soleus Capital Master Fund, L.P.
2/8/24		CA	CalciMedica, Inc.	2	SC 13G/A		Soleus Capital Master Fund, L.P.
2/6/24		CA	Harpoon Therapeutics, Inc.	2	SC 13G/A	CT	Soleus Private Equity Fund III, L.P.
2/6/24			Mereo BioPharma Group plc	2	SC 13G/A	CT	Soleus Private Equity Fund III, L.P.
2/5/24		MA	C4 Therapeutics, Inc.	3	SC 13G		Soleus Capital Master Fund, L.P.
2/2/24		MA	Pieris Pharmaceuticals, Inc.	4	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		CA	Rigel Pharmaceuticals Inc.	2	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		MA	Organogenesis Holdings Inc.	3	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		MN	Surmodics Inc.	3	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		CA	Jasper Therapeutics, Inc.	2	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		MA	Verastem, Inc.	2	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		FL	Iradimed Corp.	3	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		NJ	VYNE Therapeutics Inc.	2	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24			Edap TMS SA	5	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		NY	Delcath Systems, Inc.	2	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		FL	Axogen, Inc.	2	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		CA	NeuroPace Inc.	4	SC 13G/A	CT	Soleus Private Equity Fund I, L.P.
1/10/24		NY	Immunic, Inc.	1	SC 13G	CT	Soleus Private Equity Fund III, L.P.
11/28/23			Theratechnologies Inc.	5	SC 13D		Soleus Capital Master Fund, L.P.
			More...  Please Sign In to list all 25 of them.

“Guy Levy” has been a Group Member with  12  other Group Members:

As Of	Group Member			Filings       #        Latest		With Filer     (Primary)		Issuer     (Primary)
4/16/24		CT	Soleus Capital Group, LLC	66	SC 13D/A	CT	Soleus Private Equity Fund I, L.P.	CA	BioAtla, Inc.
			Soleus Capital Master Fund, L.P.	16
		CT	Soleus Capital, LLC	66
		CT	Soleus Pe GP I, LLC	11
		CT	Soleus Private Equity GP I, LLC	11
2/9/24		•	Soleus Pe GP II, LLC	3	SC 13G/A		Soleus Capital Master Fund, L.P.	MN	Celcuity Inc.
		CT	Soleus Private Equity Fund II, L.P.	3
		•	Soleus Private Equity GP II, LLC	3
2/8/24		•	Soleus Pe GP III, LLC	10	SC 13G/A		Soleus Capital Master Fund, L.P.	CA	CalciMedica, Inc.
		CT	Soleus Private Equity Fund III, L.P.	4
		•	Soleus Private Equity GP III, LLC	10
1/9/23		CT	Soleus Ba SPV, LLC	4	SC 13D/A	CT	Soleus Private Equity Fund I, L.P.	CA	BioAtla, Inc.

As:  Signatory  (Director, Officer, Attorney, Accountant, Banker, Agent, etc.)

“Guy Levy” has been a Signatory for/with  5  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
2/8/24			Soleus Capital Master Fund, L.P.	48	SC 13G/A	CA	CalciMedica, Inc.
2/6/24		CT	Soleus Private Equity Fund III, L.P.	6	SC 13G/A	CA	Harpoon Therapeutics, Inc.
2/2/24		CT	Soleus Private Equity Fund I, L.P.	11	SC 13G/A	CA	NeuroPace Inc.
1/23/24		CT	Soleus Capital, LLC	4	SC 13G/A		ESSA Pharma Inc.
2/28/22		CA	BioAtla, Inc.	9	424B3	—

“Guy Levy” has/had a Signatory interest in  27  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
2/8/24		CA	CalciMedica, Inc.	2	SC 13G/A		Soleus Capital Master Fund, L.P.
2/6/24		CA	Harpoon Therapeutics, Inc.	2	SC 13G/A	CT	Soleus Private Equity Fund III, L.P.
2/6/24			Mereo BioPharma Group plc	2	SC 13G/A	CT	Soleus Private Equity Fund III, L.P.
2/5/24		MA	C4 Therapeutics, Inc.	3	SC 13G		Soleus Capital Master Fund, L.P.
2/2/24		MA	Pieris Pharmaceuticals, Inc.	4	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		CA	Rigel Pharmaceuticals Inc.	2	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		MA	Organogenesis Holdings Inc.	3	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		MN	Surmodics Inc.	3	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		CA	Jasper Therapeutics, Inc.	2	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		MA	Verastem, Inc.	2	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		NJ	VYNE Therapeutics Inc.	2	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24			Edap TMS SA	5	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		NY	Delcath Systems, Inc.	2	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		FL	Axogen, Inc.	2	SC 13G/A		Soleus Capital Master Fund, L.P.
2/2/24		CA	NeuroPace Inc.	4	SC 13G/A	CT	Soleus Private Equity Fund I, L.P.
1/23/24			ESSA Pharma Inc.	3	SC 13G/A	CT	Soleus Capital, LLC
1/10/24		NY	Immunic, Inc.	1	SC 13G	CT	Soleus Private Equity Fund III, L.P.
11/28/23			Theratechnologies Inc.	5	SC 13D		Soleus Capital Master Fund, L.P.
5/24/23			InspireMD, Inc.	1	SC 13G	CT	Soleus Private Equity Fund III, L.P.
2/14/23		FL	Iradimed Corp.	2	SC 13G/A		Soleus Capital Master Fund, L.P.
			More...  Please Sign In to list all 27 of them.